Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Mirikizumab for Children and Teens with Moderate-to-Severe Ulcerative Colitis or Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium France Germany Italy The Netherlands +4
  • Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis

    Recruiting

    2 1
    Investigated Diseases:
    Croatia Czechia France Greece Hungary Italy +5
  • A Phase 2a Study Evaluating the Efficacy and Safety of MK-8690 in Adults with Moderately to Severely Active Ulcerative Colitis

    Recruiting

    2 1
    France Germany Greece Italy The Netherlands Poland
  • Mesalazine Monotherapy vs Continuing Thiopurines in Older Patients with Ulcerative Colitis in Long-Term Remission

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Spain
  • A study to evaluate the safety and effectiveness of MB-001 in adults with moderate to severe ulcerative colitis

    Recruiting

    1 1
    Investigated Drugs:
    Poland
  • A study of mirikizumab levels in breast milk of breastfeeding women with ulcerative colitis or Crohn’s disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Denmark Germany Italy Poland Spain
  • A study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia France Germany +9
  • A study testing duvakitug for patients with moderately to severely active ulcerative colitis

    Recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia France Germany +9
  • Comparing mirikizumab versus azathioprine with glucocorticoids in newly diagnosed patients with moderate-to-severe ulcerative colitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Long-term safety study of tulisokibart in adults with Crohn’s disease or ulcerative colitis

    Recruiting

    3 1
    Investigated Drugs:
    Czechia France Hungary Poland